Funding Clinical Trials
Funding Clinical Trials
Our Agency funds clinical trials testing promising stem cell or gene therapies for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.
CIRM Clinical Dashboard
Disease Areas |
Investigator | Organization | Phase | Trial Status | Targeted Enrollment | Detail |
|---|---|---|---|---|---|---|
| Ralph Kern | BrainStorm Cell Therapeutics | Phase 3 | Completed | 263 | ||
| Clive Svendsen | Cedars-Sinai Medical Center | Phase 1/2 | Completed | 18 | ||
| Clive Svendsen | Cedars-Sinai Medical Center | Phase 1 | Launching | N/A | ||
|
Robert Hayes | Immusoft Corporation | Phase 1 | Launching | N/A | |
|
Cory Nicholas | Neurona Therapeutics | Phase 1 | Recruiting | 40 | |
| Vicki Wheelock | University of California, Davis | Phase 1/2 | Completed | 29 | ||
| Krystof Bankiewicz | Brain Neurotherapy Bio | Phase 1 | Active, not recruiting | 11 | ||
|
Diana Farmer | University of California, Davis | Phase 1 | Recruiting | 55 | |
| Jane Lebkowski | Geron Corporation | Phase 1 | Completed | 5 | ||
| Francois Binette | Lineage Cell Therapeutics, Inc. | Phase 1/2 | Completed | 25 | ||
| Bijan Nejadnik | SanBio, Inc. | Phase 2 | Completed | 163 | ||
| Gary Steinberg | Stanford University | Phase 1 | Recruiting | 30 |
